Colgate-Palmolive Company

Colgate-Palmolive’s latest 10-Q, an interim financial report providing an update between annual filings, presents a document notable for its emphasis on continuity rather than new disclosures. The MD&A, or Management’s Discussion and Analysis of Financial Condition and Results of Operations, states that there has been no material change in the information reported regarding market risk exposures since the prior annual report. This suggests a stable operational environment, at least as perceived by management, concerning foreign currency, interest rate, commodity price, and credit risk. The evaluation of disclosure controls and procedures also concluded effectiveness, with participation from senior management.

The quantitative forensic scores, designed to flag potential accounting issues or financial distress, are not available in this interim filing. This means we cannot apply Beneish’s M-Score, a 1999 eight-ratio earnings-manipulation detector, nor Altman’s Z″, a 1968 bankruptcy-distress index. Similarly, Piotroski’s F-Score, a 9-point fundamental strength scan, and the Fog Index, a readability score where 18+ indicates obfuscation, are also absent. The lack of these specific metrics in the prompt means the filing itself does not offer these particular quantitative flags for analysis.

However, the filing does disclose specific capital allocation activity. Under Item 1A, the Company noted that its Board authorized a new share repurchase program (the “2025 Program”) on March 20, 2025, allowing for the repurchase of up to $5 billion of common stock. A share repurchase program is when a company buys its own stock from the open market, which can reduce the number of outstanding shares and potentially boost earnings per share. This program replaced a previously authorized one, indicating an ongoing strategy of returning capital to shareholders and managing share count.

This 10-Q, therefore, primarily serves as an affirmation of the status quo established in the prior 10-K. It does not introduce new material risks or changes to market risk management, nor does it provide the quantitative inputs necessary for a forensic accounting deep dive using established academic models. While the share repurchase program is a concrete action, the filing itself offers limited new information for assessing potential mispricing beyond what an annual report would typically provide.